Celebrating Intralipid success in the West Midlands
Midland Fertility celebrates Easter by reporting the first births of babies in the West Midlands following ‘intralipid therapy’.
Intralipid infusion therapy is a liquid fat emulsion containing chicken egg yolk and soy oil. It is used to suppress natural killer cells that are found in the body that can act against an embryo, preventing its successful implantation during an IVF cycle.
A woman’s natural immune system can also impact upon the early progress of a transferred embryo which can cause early miscarriage. The intralipid infusion that is administered intravenously, can also help combat this.
Midland Fertility was the first clinic to introduce this revolutionary therapy to the West Midlands.
Dr Abey Eapen, clinical lead at Midland Fertility said “We are very excited about the results using the infusions as we are now seeing the births of babies whose mums received intralipid infusions during their IVF or ICSI treatment.”
Issued: 18 April 2014
MFS was established in 1987 and is licensed by the Human Fertilisation and Embryology Authority to offer a range of fertility treatments and procedures including IVF, ICSI, egg donation, egg and embryo freezing and sperm recovery. In May 2002 the UK’s first ‘frozen egg’ baby was born following treatment at MFS. In September 2005, the UK’s first twins were born from ‘frozen eggs’ fertility treatment at MFS, followed by the first ‘frozen egg’ boy in December 2005. In April 2006 the clinic’s first twins were born following the mother’s treatment with Vi4gr4 as part of her fertility treatment at MFS. In early 2008, the 4,000th baby was born after treatment at MFS and the clinic celebrated its 21anniversary. The clinic’s and the UK’s first two vitrified egg babies were born in December 2010 and January 2011, followed by ‘MFS Baby 5,500′ in October 2012. In 2012 MFS marked 25 years of ‘making babies’. Based in Aldridge, West Midlands, MFS treats both private and NHS patients.